Frédéric Michel Lamoth

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


168 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
In press
 
Exploration of novel mechanisms of azole resistance in Candida auris.
Li J., Brandalise D., Coste A.T., Sanglard D., Lamoth F. Antimicrobial agents and chemotherapy. Peer-reviewed.
[DOI][Pmid][serval:BIB_833F84ADFDA1]
2024
 
Ume6-dependent pathways of morphogenesis and biofilm formation in Candida auris.
Louvet M., Li J., Brandalise D., Bachmann D., Sala de Oyanguren F., Labes D., Jacquier N., Genoud C., Mucciolo A., Coste A.T. et al., 2024/11/05. Microbiology spectrum, 12 (11) pp. e0153124. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21541699EAF6]
 
European Study of Cerebral Aspergillosis treated with Isavuconazole (ESCAI): A study by the ESCMID Fungal Infection Study Group.
Serris A., Rautemaa-Richardson R., Laranjinha J.D., Candoni A., Garcia-Vidal C., Alastruey-Izquierdo A., Hammarström H., Seidel D., Styczynski J., Sabino R. et al., 2024/10/15. Clinical infectious diseases, 79 (4) pp. 936-943. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_835D7D75C12A]
 
Role of source control in critically ill candidemic patients: a multicenter retrospective study.
Marangos M., Ioannou P., Senn L., Spiliopoulou A., Tzalis S., Kolonitsiou F., Valta M., Kokkini S., Pagani J.L., Stafylaki D. et al., 2024/10. Infection, 52 (5) pp. 1733-1743. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E12FF5C85FA]
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual.
Yeoh K., Lass-Flörl C., Lamoth F., Slavin M.A., Williams E., Neofytos D., 2024/08. Transplant infectious disease, 26 (4) pp. e14273. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6497609B679D]
 
Antifungal drug penetration in soft tissue abscesses: a comparative analysis.
Cancela Costa A., Kritikos A., Glampedakis E., Da Silva Pereira Clara J., Schaller F., Mercier T., Strasser R., Balmpouzis Z., Koutsokera A., Manuel O. et al., 2024/07/01. The Journal of antimicrobial chemotherapy, 79 (7) pp. 1668-1672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_94BC817AB3D7]
 
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease.
Hoenigl M., Arastehfar A., Arendrup M.C., Brüggemann R., Carvalho A., Chiller T., Chen S., Egger M., Feys S., Gangneux J-P et al., 2024/06/13. Clinical microbiology reviews, 37 (2) pp. e0007423. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_820F4708FB65]
Antifungal Treatment Duration in Hematology Patients With Invasive Mold Infections: A Real-life Update.
Portillo V., Ragozzino S., Stavropoulou E., El-Khoury C., Bochud P.Y., Lamoth F., Khanna N., Neofytos D., 2024/05. Open forum infectious diseases, 11 (5) pp. ofae201. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB82840AB3F4]
Isavuconazole for the Treatment of Fungal Infections: A Real-life Experience From the Fungal Infection Network of Switzerland (FUNGINOS).
Couchepin J., Reinhold I., Kronig I., Guidi M., Buclin T., Schreiber P.W., Neofytos D., Lamoth F., Fungal Infection Network of Switzerland (FUNGINOS), 2024/05. Open forum infectious diseases, 11 (5) pp. ofae223. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7689B1E13106]
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M., Giacobbe D.R., Agvald-Ohman C., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E., Blot S., Cornely O.A., Cuenca-Estrella M. et al., 2024/04. Intensive care medicine, 50 (4) pp. 502-515. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F8D4AD6C304]
 
PCR diagnostic platforms for non-Aspergillus mold infections: ready for routine implementation in the clinic?
Lamoth F., Kontoyiannis D.P., 2024/04. Expert review of molecular diagnostics, 24 (4) pp. 273-282. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C4A39ECDF6EF]
Investigations of an increased incidence of non-Aspergillus invasive mould infections in an onco-haematology unit.
Stavropoulou E., Huguenin A., Caruana G., Opota O., Perrottet N., Blanc D.S., Grandbastien B., Senn L., Bochud P.Y., Lamoth F., 2024/03/26. Swiss medical weekly, 154 p. 3730. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4091A856E587]
Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.
Filippidis P., Hovius L., Tissot F., Orasch C., Flückiger U., Siegemund M., Pagani J.L., Eggimann P., Marchetti O., Lamoth F. et al., 2024/03/11. Journal of critical care, 82 p. 154772. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BB2800A65195]
 
Lung and sinus fungal infection imaging in immunocompromised patients.
Lamoth F., Prakash K., Beigelman-Aubry C., Baddley J.W., 2024/03. Clinical microbiology and infection, 30 (3) pp. 296-305. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4DC53B97B3DF]
Upc2-mediated mechanisms of azole resistance in Candida auris.
Li J., Aubry L., Brandalise D., Coste A.T., Sanglard D., Lamoth F., 2024/02/06. Microbiology spectrum, 12 (2) pp. e0352623. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D81064ADA623]
2023
Occurrence of Aspergillus fumigatus azole resistance in soils from Switzerland.
Schürch S., Gindro K., Schnee S., Dubuis P.H., Codina J.M., Wilhelm M., Riat A., Lamoth F., Sanglard D., 2023/11/06. Medical mycology, 61 (11) pp. myad110. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_33FFF4F070B5]
Atypical imaging patterns during lung invasive mould diseases: lessons for clinicians.
Casutt A., Lamoth F., Lortholary O., Prior J.O., Tonglet A., Manuel O., Bergeron A., Beigelman-Aubry C., 2023/09/30. European respiratory review, 32 (169). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6BA7EC326862]
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?
Albrich W.C., Lamoth F., 2023/08/01. American journal of respiratory and critical care medicine, 208 (3) pp. 230-231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4D978DCE1AD4]
Performance of the beta-glucan test for the diagnosis of invasive fusariosis and scedosporiosis: a meta-analysis.
Lamoth F., Nucci M., Fernandez-Cruz A., Azoulay E., Lanternier F., Bremerich J., Einsele H., Johnson E., Lehrnbecher T., Mercier T. et al., 2023/07/06. Medical mycology, 61 (7). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_898CA72EA941]
Clinically relevant bidirectional drug-drug interaction between midostaurin and voriconazole.
Haefliger D., Marzolini C., Lamoth F., Pabst T., Buclin T., Livio F., 2023/07. British journal of clinical pharmacology, 89 (7) pp. 2304-2308. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9BC838D4B328]
Novel Approaches in the Management of Mucormycosis
Lamoth Frederic, 2023/06. Current Fungal Infection Reports, 17 (2) pp. 98-107.
[URN][DOI][WoS][Pmid][serval:BIB_FA10AFF52769]
 
Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
Li J., Coste A.T., Liechti M., Bachmann D., Sanglard D., Lamoth F., 2023/05/01. Antimicrobial agents and chemotherapy, 65 (5) pp. e02663-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82EB6D2906CE]
What Is New in Pulmonary Mucormycosis?
Danion F., Coste A., Le Hyaric C., Melenotte C., Lamoth F., Calandra T., Garcia-Hermoso D., Aimanianda V., Lanternier F., Lortholary O., 2023/02/28. Journal of fungi, 9 (3) p. 307. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC89D4B5FCED]
 
Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
Kritikos A., Caruana G., Poissy J., Mamin A., Bachmann D., Pagani J.L., Coste A.T., Lamoth F., 2023/02/22. Journal of clinical microbiology, 61 (2) pp. e0169122. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_24963B96DCC0]
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Maertens J., Lodewyck T., Donnelly J.P., Chantepie S., Robin C., Blijlevens N., Turlure P., Selleslag D., Baron F., Aoun M. et al., 2023/02/18. Clinical infectious diseases, 76 (4) pp. 674-682. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E34CCCFF4BB8]
Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician.
Lamoth F., 2023. Infection and drug resistance, 16 pp. 1087-1097. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0FEB39DECCD1]
2022
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F., Calandra T., 2022/12/31. European respiratory review, 31 (166) p. 220114. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D58141CCAB19]
 
Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia.
Bergeron A., Mikulska M., De Greef J., Bondeelle L., Franquet T., Herrmann J.L., Lange C., Spriet I., Akova M., Donnelly J.P. et al., 2022/12. The Lancet. Infectious diseases, 22 (12) pp. e359-e369. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D27571AAE071]
 
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis.
Giacobbe D.R., Asperges E., Cortegiani A., Grecchi C., Rebuffi C., Zuccaro V., Scudeller L., Bassetti M., FUNDICU investigators, 2022/12. Mycoses, 65 (12) pp. 1073-1111. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_29BAF1D8832A]
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data.
Bassetti M., Zuccaro V., Asperges E., Scudeller L., Giacobbe D.R., FUNDICU investigators (collaborators), 2022/11. The Journal of infection, 85 (5) pp. 573-607. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_952422A46B1B]
Surgical site infections after simultaneous pancreas kidney and pancreas transplantation in the Swiss Transplant Cohort Study.
Schreiber P.W., Laager M., Boggian K., Neofytos D., van Delden C., Egli A., Dickenmann M., Hirzel C., Manuel O., Koller M. et al., 2022/10. The Journal of hospital infection, 128 pp. 47-53. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0CFE763A8A63]
 
Investigational Antifungal Agents for Invasive Mycoses: A Clinical Perspective.
Lamoth F., Lewis R.E., Kontoyiannis D.P., 2022/08/31. Clinical infectious diseases, 75 (3) pp. 534-544. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90F243509573]
 
High False-Positive Rate of (1,3)-β-D-Glucan in Onco-Hematological Patients Receiving Immunoglobulins and Therapeutic Antibodies.
Tschopp J., Brunel A.S., Spertini O., Croxatto A., Lamoth F., Bochud P.Y., 2022/08/25. Clinical infectious diseases, 75 (2) pp. 330-333. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D7EA460AD1EC]
Κey Role of Early Source Control in Candidemic Patients With Sepsis or Septic Shock.
Papadimitriou-Olivgeris M., Battistolo J., Poissy J., Coste A., Bochud P.Y., Calandra T., Senn L., Lamoth F., 2022/08. Open forum infectious diseases, 9 (8) pp. ofac383. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16BC39E44CF1]
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
Kusejko K., Chammartin F., Smith D., Odermatt M., Schuhmacher J., Koller M., Günthard H.F., Briel M., Bucher H.C., Speich B. et al., 2022/07/28. BMC infectious diseases, 22 (1) p. 654. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_66CD4B7631A4]
Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.
Born T., Aruanno M., Kampouri E., Mombelli M., Monney P., Tozzi P., Lamoth F., 2022/06. Mycopathologia, 187 (2-3) pp. 249-258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B27A401AB555]
 
The unresolved issues in the management of mucormycosis.
Lamoth F., 2022/06. European journal of internal medicine, 100 pp. 29-30. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DF603E67DBB5]
Anti-SARS-CoV-2 Titers Predict the Severity of COVID-19.
Kritikos A., Gabellon S., Pagani J.L., Monti M., Bochud P.Y., Manuel O., Coste A., Greub G., Perreau M., Pantaleo G. et al., 2022/05/18. Viruses, 14 (5) p. 1089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7AA364497D07]
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period.
Lazor-Blanchet C., Zygoura P., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Grandbastien B., Fenwick C., Pantaleo G. et al., 2022/05. The Journal of infection, 84 (5) pp. 722-746. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AB5408AF350D]
 
Deciphering the Mrr1/Mdr1 Pathway in Azole Resistance of Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2022/04/19. Antimicrobial agents and chemotherapy, 66 (4) pp. e0006722. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_89B82C9DD605]
Tularémie pulmonaire : un diagnostic à ne pas manquer [Pulmonary tularemia : a diagnosis not to be missed]
Uriel Valladares P., Opota O., Beigelman-Aubry C., Bochud P.Y., Lamoth F., 2022/04/13. Revue medicale suisse, 18 (777) pp. 707-711. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_4200435B5420]
 
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians.
Lamoth F., 2022/04/01. Current opinion in infectious diseases, 35 (2) pp. 163-169. Peer-reviewed.
[DOI][Pmid][serval:BIB_8E913CA78F8C]
Distribution of Aspergillus Species and Prevalence of Azole Resistance in Respiratory Samples From Swiss Tertiary Care Hospitals.
Ragozzino S., Goldenberger D., Wright P.R., Zimmerli S., Mühlethaler K., Neofytos D., Riat A., Boggian K., Nolte O., Conen A. et al., 2022/02. Open forum infectious diseases, 9 (2) pp. ofab638. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3DDAB3B39B65]
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections.
Roth R.S., Masouridi-Levrat S., Giannotti F., Mamez A.C., Glambedakis E., Lamoth F., Bochud P.Y., Erard V., Emonet S., Van Delden C. et al., 2022/02. Mycoses, 65 (2) pp. 199-210. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FC19CC73388A]
 
Case report: Disseminated Scedosporium apiospermum infection with invasive right atrial mass in a heart transplant patient.
Bourlond B., Cipriano A., Regamey J., Papadimitriou-Olivgeris M., Kamani C., Seidel D., Lamoth F., Muller O., Yerly P., 2022. Frontiers in cardiovascular medicine, 9 p. 1045353. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_653060C72977]
How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
Pellaton N., Sanglard D., Lamoth F., Coste A.T., 2022. Frontiers in cellular and infection microbiology, 12 p. 859439. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC99145B5F54]
2021
Assessment of the In Vitro and In Vivo Antifungal Activity of NSC319726 against Candida auris.
Li J., Coste A.T., Bachmann D., Sanglard D., Lamoth F., 2021/12/22. Microbiology spectrum, 9 (3) pp. e0139521. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A88593023DD0]
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital.
Battistolo J., Glampedakis E., Damonti L., Poissy J., Grandbastien B., Kalbermatter L., Pagani J.L., Eggimann P., Bochud P.Y., Calandra T. et al., 2021/12. Mycoses, 64 (12) pp. 1512-1520. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_59B304F1CB77]
 
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis.
Lamoth F., Lewis R.E., Walsh T.J., Kontoyiannis D.P., 2021/11/22. The Journal of infectious diseases, 224 (10) pp. 1631-1640. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4FB69C41F305]
Trends of the Epidemiology of Candidemia in Switzerland: A 15-Year FUNGINOS Survey.
Adam K.M., Osthoff M., Lamoth F., Conen A., Erard V., Boggian K., Schreiber P.W., Zimmerli S., Bochud P.Y., Neofytos D. et al., 2021/10. Open forum infectious diseases, 8 (10) pp. ofab471. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E1C2CA5BE723]
COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Fekkar A., Neofytos D., Nguyen M.H., Clancy C.J., Kontoyiannis D.P., Lamoth F., 2021/09. Clinical microbiology and infection, 27 (9) pp. 1376-1378. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_16E52ACE988B]
Pancreatitis, hypereosinophilia and bilateral pulmonary infiltrates as presentation of acute Q fever.
Cancela Costa A., Chheang C., Thorens O., Lamy O., Prella M., Babaker M., Lamoth F., Greub G., 2021/09. New microbes and new infections, 43 p. 100940. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6025077A999E]
 
Insights in the molecular mechanisms of an azole stress adapted laboratory-generated Aspergillus fumigatus strain.
Aruanno M., Gozel S., Mouyna I., Parker J.E., Bachmann D., Flamant P., Coste A.T., Sanglard D., Lamoth F., 2021/07/14. Medical mycology, 59 (8) pp. 763-772. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B19CC367C75B]
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_471F833F0211]
Limited Index of Clinical Suspicion and Underdiagnosis of Histopathologically Documented Invasive Mold Infections.
Caudron de Coquereaumont G., Couchepin J., Perentes J.Y., Krueger T., Lovis A., Rotman S., Lamoth F., 2021/07. Open forum infectious diseases, 8 (7) pp. ofab174. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5A84A71FF9C5]
Invasive Hormographiella aspergillata infection in patients with acute myeloid leukemia: Report of two cases successfully treated and review of the literature.
Tschopp J., Perentes J.Y., Beigelman-Aubry C., Berezowska S., Lovis A., Spertini O., Bochud P.Y., Lamoth F., 2021/06. Medical mycology case reports, 32 pp. 68-72. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_723A4B6AD287]
 
Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.
Glampedakis E., Cassaing S., Fekkar A., Dannaoui E., Bougnoux M.E., Bretagne S., Neofytos D., Schreiber P.W., Hennequin C., Morio F. et al., 2021/04/26. Clinical infectious diseases, 72 (8) pp. 1379-1385. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_102BDCBA5418]
Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response.
Neofytos D., Garcia-Vidal C., Lamoth F., Lichtenstern C., Perrella A., Vehreschild J.J., 2021/03/24. BMC infectious diseases, 21 (1) p. 296. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D96B6F63A459]
 
Assessment of the Role of 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Fungal Infections in Adults.
Lamoth F., Akan H., Andes D., Cruciani M., Marchetti O., Ostrosky-Zeichner L., Racil Z., Clancy C.J., 2021/03/12. Clinical infectious diseases, 72 (Suppl 2) pp. S102-S108. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_309237C62F3D]
 
Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC.
Alexander B.D., Lamoth F., Heussel C.P., Prokop C.S., Desai S.R., Morrissey C.O., Baddley J.W., 2021/03/12. Clinical infectious diseases, 72 (Suppl 2) pp. S79-S88. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A50B79E65CCB]
 
Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.
Giacobbe D.R., Cortegiani A., Karaiskos I., Mercier T., Tejada S., Peghin M., Grecchi C., Rebuffi C., Asperges E., Zuccaro V. et al., 2021/02/28. Journal of fungi, 7 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_617977024687]
Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".
Kritikos A., Lamoth F., 2021/02/09. Critical care, 25 (1) p. 55. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_155FE2BCB2B9]
Invasive Pulmonary Aspergillosis Goes Viral Again?
Wauters J., Lamoth F., Rijnders BJA, Calandra T., 2021/02/01. American journal of respiratory and critical care medicine, 203 (3) pp. 275-277. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_290519991FFF]
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.
Vehreschild J.J., Koehler P., Lamoth F., Prattes J., Rieger C., Rijnders BJA, Teschner D., 2021/01/04. Medical mycology, 59 (1) pp. 93-101. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6C5F63C5F5B2]
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
Filippidis P., van Ouwenaller F., Cerutti A., Geiger-Jacquod A., Sempoux C., Pantaleo G., Moradpour D., Lamoth F., 2021. F1000Research, 10 p. 400. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0194C4870252]
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S., Guex N., Lourenco J., Brahier T., Papadimitriou-Olivgeris M., Damonti L., Manuel O., Liechti R., Götz L., Tschopp J. et al., 2021. Frontiers in immunology, 12 p. 666163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91CEC9119F7E]
2020
Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.
Lamoth F., Lewis R.E., Kontoyiannis D.P., 2020/12/30. Journal of fungi, 7 (1) pp. E17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62F309E67A3E]
Incidence of invasive pulmonary aspergillosis among critically ill COVID-19 patients.
Lamoth F., Glampedakis E., Boillat-Blanco N., Oddo M., Pagani J.L., 2020/12. Clinical microbiology and infection, 26 (12) pp. 1706-1708. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8331B09AD13F]
Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
Decosterd L.A., Mercier T., Ternon B., Cruchon S., Guignard N., Lahrichi S., Pesse B., Rochat B., Burger R., Lamoth F. et al., 2020/11/10. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1157 p. 122160. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ABB9B287690]
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
Othenin-Girard A., Regamey J., Lamoth F., Horisberger A., Glampedakis E., Epiney J.B., Kuntzer T., de Leval L., Carballares M., Hurni C.A. et al., 2020/11/02. Swiss medical weekly, 150 pp. w20387. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_135A96CD7E72]
Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement.
Jenks J.D., Gangneux J.P., Schwartz I.S., Alastruey-Izquierdo A., Lagrou K., Thompson Iii G.R., Lass-Flörl C., Hoenigl M., European Confederation of Medical Mycology (ECMM) Council Investigators, 2020/10/11. Journal of fungi, 6 (4). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_561A87B88814]
 
COVID-19 Pandemics: A Surprising Link to Bread Flour With Collateral Damage to a Prosthetic Heart Valve.
Tozzi P., Kampouri E.E., Tzimas G., Prior J.O., Monney P., Kamani C., Lamoth F., 2020/10. Circulation. Cardiovascular imaging, 13 (10) pp. e011395. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6AAEE9B61C26]
Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland.
Coste A.T., Kritikos A., Li J., Khanna N., Goldenberger D., Garzoni C., Zehnder C., Boggian K., Neofytos D., Riat A. et al., 2020/10. Infection, 48 (5) pp. 761-766. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EF468599D088]
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Donnelly J Peter, Chen Sharon C, Kauffman Carol A, Steinbach William J, Baddley John W, Verweij Paul E, Clancy Cornelius J, Wingard John R, Lockhart Shawn R, Groll Andreas H et al., 2020/09/12. Clinical Infectious Diseases, 71 (6) pp. 1367-1376. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E65A6649EFA]
Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results.
Caruana G., Croxatto A., Coste A.T., Opota O., Lamoth F., Jaton K., Greub G., 2020/09. Clinical microbiology and infection, 26 (9) pp. 1178-1182. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EB349E4D572A]
 
High prevalence of peribronchial focal lesions of airway invasive aspergillosis in hematological cancer patients with prolonged neutropenia.
Casutt A., Couchepin J., Brunel A.S., Lovis A., Bochud P.Y., Keller N., Lamoth F., Beigelman-Aubry C., 2020/09/01. The British journal of radiology, 93 (1113) p. 20190693. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0779912D40B1]
 
Incidentally discovered COVID-19 pneumonia: the role of diagnostic imaging.
Pozzessere C., Rotzinger D.C., Ghaye B., Lamoth F., Beigelman-Aubry C., 2020/09. European radiology, 30 (9) pp. 5211-5213. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_98DE1603D705]
Conidiobolus pachyzygosporus invasive pulmonary infection in a patient with acute myeloid leukemia: case report and review of the literature.
Stavropoulou E., Coste A.T., Beigelman-Aubry C., Letovanec I., Spertini O., Lovis A., Krueger T., Burger R., Bochud P.Y., Lamoth F., 2020/07/22. BMC infectious diseases, 20 (1) p. 527. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_8DBE542AD411]
Collapsing glomerulopathy in a COVID-19 patient.
Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F., 2020/07. Kidney international, 98 (1) pp. 228-231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_251429356BF9]
 
Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis
Bassetti M., Giacobbe D.R., Grecchi C., Rebuffi C., Zuccaro V., Scudeller L., Akova M., Alastruey-Izquierdo A., Arikan-Akdagli S., Azoulay E. et al., 2020/07. Journal of Infection, 81 (1) pp. 131-146.
[DOI][WoS][Pmid][serval:BIB_2A39F40A3E05]
Clinical Relevance and Characteristics of Aspergillus calidoustus and Other Aspergillus Species of Section Usti.
Glampedakis E., Erard V., Lamoth F., 2020/06/12. Journal of fungi, 6 (2). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_3E8FE6BF70D1]
SARS-CoV-2, un point dans la tourmente [SARS-CoV-2, a point in the storm]
Tadini E., Papamidimitriou-Olivgeris M., Opota O., Moulin E., Lamoth F., Manuel O., Lhopitallier L., Jaton K., Croxatto A., Grandbastien B. et al., 2020/05/06. Revue medicale suisse, 16 (692) pp. 917-923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_88A8DA997C5D]
Ability of quantitative PCR to discriminate Pneumocystis jirovecii pneumonia from colonization.
Perret T., Kritikos A., Hauser P.M., Guiver M., Coste A.T., Jaton K., Lamoth F., 2020/05. Journal of medical microbiology, 69 (5) pp. 705-711. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_BFDF364602B9]
 
Impact of the Beta-Glucan Test on Management of Intensive Care Unit Patients at Risk for Invasive Candidiasis
Kritikos Antonios, Poissy Julien, Croxatto Antony, Bochud Pierre-Yves, Pagani Jean-Luc, Lamoth Frederic, 2020/04/01. Journal of Clinical Microbiology, 58 (6) pp. e01996-19. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BEDA4FB01DB]
Risk factors for candidemia: a prospective matched case-control study.
Poissy J., Damonti L., Bignon A., Khanna N., Von Kietzell M., Boggian K., Neofytos D., Vuotto F., Coiteux V., Artru F. et al., 2020/03/18. Critical care, 24 (1) p. 109. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A42B1C805146]
Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis.
Lamoth F., Clancy C.J., Tissot F., Squires K., Eggimann P., Flückiger U., Siegemund M., Orasch C., Zimmerli S., Calandra T. et al., 2020/03. Open forum infectious diseases, 7 (3) pp. ofaa075. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_55AFFF4235BB]
2019
 
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.
Cornely O.A., Alastruey-Izquierdo A., Arenz D., Chen SCA, Dannaoui E., Hochhegger B., Hoenigl M., Jensen H.E., Lagrou K., Lewis R.E. et al., 2019/12. The Lancet. Infectious diseases, 19 (12) pp. e405-e421. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_79ADD598DDAD]
 
Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.
Lamoth F., Kontoyiannis D.P., 2019/11. Antimicrobial agents and chemotherapy, 63 (11). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DFF4349F2518]
 
Successful treatment with daptomycin and ceftaroline of MDR Staphylococcus aureus native valve endocarditis: a case report.
Duss F.R., Garcia de la Mària C., Croxatto A., Giulieri S., Lamoth F., Manuel O., Miró J.M., 2019/09/01. The Journal of antimicrobial chemotherapy, 74 (9) pp. 2626-2630. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2B99F3F57E16]
 
Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside.
Aruanno M., Glampedakis E., Lamoth F., 2019/08. Antimicrobial agents and chemotherapy, 63 (8). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5956AF923F85]
Link between Heat Shock Protein 90 and the Mitochondrial Respiratory Chain in the Caspofungin Stress Response of Aspergillus fumigatus.
Aruanno M., Bachmann D., Sanglard D., Lamoth F., 2019/07. Antimicrobial agents and chemotherapy, 63 (7) pp. e00208-19.. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27BC0FBB5DCD]
 
Isavuconazole brain penetration in cerebral aspergillosis.
Lamoth F., Mercier T., André P., Pagani J.L., Pantet O., Maduri R., Guery B., Decosterd L.A., 2019/06/01. The Journal of antimicrobial chemotherapy, 74 (6) pp. 1751-1753. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBC07C267A48]
 
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Bassetti M., Scudeller L., Giacobbe D.R., Lamoth F., Righi E., Zuccaro V., Grecchi C., Rebuffi C., Akova M., Alastruey-Izquierdo A. et al., 2019/04. Mycoses, 62 (4) pp. 310-319. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A6CB07C270A8]
 
Diagnostic approach to encephalitis and meningoencephalitis in adult returning travellers.
Kenfak A., Eperon G., Schibler M., Lamoth F., Vargas M.I., Stahl J.P., 2019/04. Clinical microbiology and infection, 25 (4) pp. 415-421. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BC9C07578E92]
 
Diagnosis and treatment of invasive fungal infections: looking ahead.
Sanguinetti M., Posteraro B., Beigelman-Aubry C., Lamoth F., Dunet V., Slavin M., Richardson M.D., 2019/03/01. The Journal of antimicrobial chemotherapy, 74 (Supplement_2) pp. ii27-ii37. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD93B62C73F3]
 
Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
White P.L., Barnes R.A., Gorton R., Cruciani M., Loeffler J., Fungal PCR Initiative (Working Group of the International Society of Human and Animal Mycology), 2019/02/01. The Journal of antimicrobial chemotherapy, 74 (2) pp. 532-533. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8DE70665EBD4]
2018
 
Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.
Burger R., Guidi M., Calpini V., Lamoth F., Decosterd L., Robatel C., Buclin T., Csajka C., Marchetti O., 2018/12/01. The Journal of antimicrobial chemotherapy, 73 (12) pp. 3413-3422. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C826664F7442]
 
Efficacy of Antifungal Monotherapies and Combinations against Aspergillus calidoustus.
Glampedakis E., Coste A.T., Aruanno M., Bachmann D., Delarze E., Erard V., Lamoth F., 2018/12. Antimicrobial agents and chemotherapy, 62 (12). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96BD38D42E6D]
 
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A., Neofytos D., Khanna N., Schreiber P.W., Boggian K., Bille J., Schrenzel J., Mühlethaler K., Zbinden R., Bruderer T. et al., 2018/11. Clinical microbiology and infection, 24 (11) pp. 1214.e1-1214.e4. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CDB7569EE916]
 
Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.
Brunel A.S., Wójtowicz A., Lamoth F., Spertini O., Neofytos D., Calandra T., Marchetti O., Bochud P.Y., 2018/11. Haematologica, 103 (11) pp. e527-e530. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57E679722B16]
 
Let's add invasive aspergillosis to the list of influenza complications.
Lamoth F., Calandra T., 2018/10. The Lancet. Respiratory medicine, 6 (10) pp. 733-735. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A300B8F74F8]
 
Role of bi-weekly serum galactomannan screening for the diagnosis of invasive aspergillosis in haematological cancer patients.
Couchepin J., Brunel A.S., Jaton K., Meylan P., Bochud P.Y., Lamoth F., 2018/06. Mycoses, 61 (6) pp. 350-354. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5633E535BA9A]
 
Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.
Orasch C., Mertz D., Garbino J., van Delden C., Emonet S., Schrenzel J., Zimmerli S., Damonti L., Mühlethaler K., Imhof A. et al., 2018/05. The Journal of infection, 76 (5) pp. 489-495. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AB78279BDFD7]
 
Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Damonti L., Erard V., Garbino J., Schrenzel J., Zimmerli S., Mühlethaler K., Imhof A., Zbinden R., Fehr J., Boggian K. et al., 2018/03..
[DOI][WoS][Pmid][serval:BIB_57775AC05AC1]
 
The Candida auris Alert: Facts and Perspectives.
Lamoth F., Kontoyiannis D.P., 2018/01/30. The Journal of infectious diseases, 217 (4) pp. 516-520. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F8BCC891BE3]
 
Changes in the epidemiological landscape of invasive candidiasis.
Lamoth F., Lockhart S.R., Berkow E.L., Calandra T., 2018/01/01. The Journal of antimicrobial chemotherapy, 73 (suppl_1) pp. i4-i13. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_32A16E1338F4]
First case of Candida auris in Switzerland: discussion about preventive strategies.
Riat A., Neofytos D., Coste A., Harbarth S., Bizzini A., Grandbastien B., Pugin J., Lamoth F., 2018. Swiss medical weekly, 148 pp. w14622. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C56C1C51FBC4]
2017
 
Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.
Damonti L., Erard V., Garbino J., Schrenzel J., Zimmerli S., Mühlethaler K., Imhof A., Zbinden R., Fehr J., Boggian K. et al., 2017/06. Intensive care medicine, 43 (6) pp. 935-939. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8C5A7EF6C586]
 
Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
Lamoth F., Chung S.J., Damonti L., Alexander B.D., 2017/06/01. Clinical infectious diseases, 64 (11) pp. 1619-1621. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A252D3E571DD]
 
Early diagnosis of invasive mould infections and disease.
Lamoth F., Calandra T., 2017/03/01. The Journal of antimicrobial chemotherapy, 72 (suppl_1) pp. i19-i28. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B67261FB18B2]
2016
 
Role of Antifungal Susceptibility Testing in Non-Aspergillus Invasive Mold Infections.
Lamoth F., Damonti L., Alexander B.D., 2016/06. Journal of clinical microbiology, 54 (6) pp. 1638-1640. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B31E04F5779C]
Aspergillus fumigatus-Related Species in Clinical Practice.
Lamoth F., 2016. Frontiers In Microbiology, 7 p. 683. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E9BB71C8EC5A]
Editorial: Advances in Aspergillus fumigatus Pathobiology.
Lamoth F., Juvvadi P.R., Steinbach W.J., 2016. Frontiers In Microbiology, 7 p. 43. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9113D8AEC6F7]
Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
Lamoth Frédéric, 2016. Journal of Fungi, 2 (3) p. 22.
[URN][DOI][serval:BIB_4E7659C9AD21]
 
Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus.
Lamoth F., Juvvadi P.R., Steinbach W.J., 2016. Critical reviews in microbiology, 42 (2) pp. 310-321. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8DC9F00D237F]
2015
 
Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.
Lamoth F., Alexander B.D., 2015/10. Journal of clinical microbiology, 53 (10) pp. 3176-3181. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_53691493A1D5]
Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus.
Juvvadi P.R., Muñoz A., Lamoth F., Soderblom E.J., Moseley M.A., Read N.D., Steinbach W.J., 2015/08. Antimicrobial agents and chemotherapy, 59 (8) pp. 4946-4955. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C72D6E62DE3A]
 
Hsp70 and the Cochaperone StiA (Hop) Orchestrate Hsp90-Mediated Caspofungin Tolerance in Aspergillus fumigatus.
Lamoth F., Juvvadi P.R., Soderblom E.J., Moseley M.A., Steinbach W.J., 2015/08. Antimicrobial agents and chemotherapy, 59 (8) pp. 4727-4733. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_499770B73949]
 
The Aspergillus fumigatus septins play pleiotropic roles in septation, conidiation, and cell wall stress, but are dispensable for virulence.
Vargas-Muñiz J.M., Renshaw H., Richards A.D., Lamoth F., Soderblom E.J., Moseley M.A., Juvvadi P.R., Steinbach W.J., 2015/08. Fungal genetics and biology, 81 pp. 41-51. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DBDEAF7DD266]
 
Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.
Lamoth F., Alexander B.D., 2015/07. Antimicrobial agents and chemotherapy, 59 (7) pp. 4308-4311. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0E049DEF76E3]
Antifungal activity of compounds targeting the Hsp90-calcineurin pathway against various mould species.
Lamoth F., Alexander B.D., Juvvadi P.R., Steinbach W.J., 2015. Journal of Antimicrobial Chemotherapy, 70 (5) pp. 1408-1411.
[URN][DOI][WoS][Pmid][serval:BIB_B9C8B817C021]
Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis.
Lamoth F., Juvvadi P.R., Steinbach W.J., 2015. Frontiers in Microbiology, 6 p. 96. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C8B58A407565]
Identification and mutational analyses of phosphorylation sites of the calcineurin-binding protein CbpA and the identification of domains required for calcineurin binding in Aspergillus fumigatus.
Juvvadi P. R., Ma Y., Richards A.D., Soderblom E.J., Moseley M.A., Lamoth F., Steinbach W.J., 2015. Frontiers in Microbiology, 6 p. 175. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1417A13D594B]
Potential Microbiological Effects of Higher Dosing of Echinocandins.
Steinbach W.J., Lamoth F., Juvvadi P.R., 2015. Clinical Infectious Diseases, 61 Suppl 6 pp. S669-S677. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B87BFE7C335]
 
Waddlia: An emerging pathogen and a model organism to study the biology of chlamydiae.
Lamoth F., Pillonel T., Greub G., 2015. Microbes and Infection, 17 (11-12) pp. 732-737. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D8444BF49994]
2014
 
Approches diagnostiques des bactéries intracellulaires et des germes fastidieux [Diagnostic approach of intracellular bacteria and fastidious microorganisms]
Lamoth F., Schrenzel J., Greub G., 2014/11/12. Revue medicale suisse, 10 (450) pp. 2130-2136. Peer-reviewed.
[Pmid][serval:BIB_2DCEC0ED605C]
 
Nonmolecular methods for the diagnosis of respiratory fungal infections.
Lamoth F., Alexander B.D., 2014/06. Clinics in laboratory medicine, 34 (2) pp. 315-336. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A91991E92744]
Approches diagnostiques des bactéries intracellulaires et des germes fastidieux [Diagnostic approach of intracellular bacteria and fastidious microorganisms].
Lamoth F., Schrenzel J., Greub G., 2014. Revue Médicale Suisse, 10 (450) pp. 2130-2136. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_361FDE9CECD6]
 
Calcineurin as a Multifunctional Regulator: Unraveling Novel Functions in Fungal Stress Responses, Hyphal Growth, Drug Resistance, and Pathogenesis.
Juvvadi P.R., Lamoth F., Steinbach W.J., 2014. Fungal Biology Reviews, 28 (2-3) pp. 56-69. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE00AB9FA689]
Calcineurin-Mediated Regulation of Hyphal Growth, Septation, and Virulence in Aspergillus fumigatus.
Juvvadi P.R., Lamoth F., Steinbach W.J., 2014. Mycopathologia, 178 (5-6) pp. 341-348. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA5E5228B562]
 
Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis
Lamoth Frédéric, Juvvadi Praveen R., Steinbach William J., 2014. Current Fungal Infection Reports, 8 (4) pp. 296-301.
[DOI][serval:BIB_0ACAE39A576A]
 
Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.
Lamoth F., Juvvadi P.R., Soderblom E.J., Moseley M.A., Asfaw Y.G., Steinbach W.J., 2014. Antimicrobial agents and chemotherapy, 58 (4) pp. 1889-1896. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_A10A0DCF633A]
 
Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.
Wójtowicz A., Tissot F., Lamoth F., Orasch C., Eggimann P., Siegemund M., Zimmerli S., Flueckiger U.M., Bille J., Calandra T. et al., 2014. Critical Care Medicine, 42 (4) pp. e304-e308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9E94BE692A2A]
 
Transcriptional activation of heat shock protein 90 mediated via a proximal promoter region as trigger of caspofungin resistance in Aspergillus fumigatus.
Lamoth F., Juvvadi P.R., Gehrke C., Asfaw Y.G., Steinbach W.J., 2014. Journal of Infectious Diseases, 209 (3) pp. 473-481.
[DOI][WoS][Pmid][serval:BIB_75724F4E5569]
2013
 
In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.
Lamoth F., Juvvadi P.R., Gehrke C., Steinbach W.J., 2013. Antimicrobial Agents and Chemotherapy, 57 (2) pp. 1035-1039.
[DOI][WoS][Pmid][serval:BIB_E3BEDC966E01]
Phosphorylation of Calcineurin at a novel serine-proline rich region orchestrates hyphal growth and virulence in Aspergillus fumigatus.
Juvvadi P.R., Gehrke C., Fortwendel J.R., Lamoth F., Soderblom E.J., Cook E.C., Hast M.A., Asfaw Y.G., Moseley M.A., Creamer T.P. et al., 2013. PLoS pathogens, 9 (8) pp. e1003564. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_08E1F2D8567B]
 
β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture-Negative Intraabdominal Candidiasis.
Tissot F., Lamoth F., Hauser P.M., Orasch C., Flückiger U., Siegemund M., Zimmerli S., Calandra T., Bille J., Eggimann P. et al., 2013. American Journal of Respiratory and Critical Care Medicine, 188 (9) pp. 1100-1109.
[DOI][WoS][Pmid][serval:BIB_5D0AA27187E7]
2012
 
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.
Marchetti O., Lamoth F., Mikulska M., Viscoli C., Verweij P., Bretagne S., European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups, 2012/06. Bone marrow transplantation, 47 (6) pp. 846-854. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E84C3E2378D6]
 
Heat shock protein 90 is required for conidiation and cell wall integrity in Aspergillus fumigatus.
Lamoth F., Juvvadi P.R., Fortwendel J.R., Steinbach W.J., 2012. Eukaryotic Cell, 11 (11) pp. 1324-1332.
[DOI][WoS][Pmid][serval:BIB_C14CB73FF731]
β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).
Lamoth F., Cruciani M., Mengoli C., Castagnola E., Lortholary O., Richardson M., Marchetti O., Third European Conference on Infections in Leukemia (ECIL-3), 2012. Clinical Infectious Diseases, 54 (5) pp. 633-643.
[URN][DOI][WoS][Pmid][serval:BIB_0B86B0DE8874]
2011
 
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.
Maertens J., Marchetti O., Herbrecht R., Cornely O.A., Flückiger U., Frêre P., Gachot B., Heinz W.J., Lass-Flörl C., Ribaud P. et al., 2011/05. Bone marrow transplantation, 46 (5) pp. 709-718. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CFF49E451D67]
Immunogenetics of invasive aspergillosis.
Lamoth F., Rubino I., Bochud P.Y., 2011. Medical Mycology, 49 (Suppl. 1) pp. S125-S136.
[URN][DOI][WoS][Pmid][serval:BIB_7A0766212047]
Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent Fever?
Robinson J.O., Lamoth F., Bally F., Knaup M., Calandra T., Marchetti O., 2011. Plos One, 6 (4) pp. e18886.
[URN][DOI][WoS][Pmid][serval:BIB_8777D1F23997]
Parachlamydia and rhabdochlamydia: emerging agents of community-acquired respiratory infections in children.
Lamoth F., Jaton K., Vaudaux B., Greub G., 2011. Clinical Infectious Diseases, 53 (5) pp. 500-501. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7EA707D331B4]
2010
 
Fastidious intracellular bacteria as causal agents of community-acquired pneumonia.
Lamoth F., Greub G., 2010/07. Expert review of anti-infective therapy, 8 (7) pp. 775-790. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BA0920F22E87]
 
Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection.
Lebeau O., Van Delden C., Garbino J., Robert J., Lamoth F., Passweg J., Chalandon Y., 2010/06. Transplant infectious disease, 12 (3) pp. 269-272. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9B72D655480E]
Amoebal pathogens as emerging causal agents of pneumonia.
Lamoth Frederic, Greub Gilbert, 2010. Fems Microbiology Reviews, 34 (3) pp. 260-280.
[URN][DOI][WoS][Pmid][serval:BIB_FB7AFE6B97C1]
Comparison of hospital-wide and unit-specific cumulative antibiograms in hospital- and community-acquired infection.
Lamoth F., Wenger A., Prod'hom G., Vallet Y., Plüss-Suard C., Bille J., Zanetti G., 2010. Infection, 38 (4) pp. 249-253. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D186294804C4]
 
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study.
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Meylan P.R., 2010. Clinical transplantation, 24 (6) pp. 794-800. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F844F8046356]
 
High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.
Lamoth F., Buclin T., Pascual A., Vora S., Bolay S., Decosterd L.A., Calandra T., Marchetti O., 2010. Antimicrobial Agents and Chemotherapy, 54 (10) pp. 4360-4367.
[DOI][WoS][Pmid][serval:BIB_5A96268D6970]
 
Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.
Lamoth F., Jaton K., Prod'hom G., Senn L., Bille J., Calandra T., Marchetti O., 2010. Journal of Clinical Microbiology, 48 (10) pp. 3510-3516.
[DOI][WoS][Pmid][serval:BIB_A64C6B86455E]
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.
Mikulska M., Calandra T., Sanguinetti M., Poulain D., Viscoli C., Third European Conference on Infections in Leukemia Group, 2010. Critical Care, 14 (6) pp. R222.
[URN][DOI][WoS][Pmid][serval:BIB_059C5E3D1FD5]
 
Ultra-performance liquid chromatography mass spectrometry and sensitive bioassay methods for quantification of posaconazole plasma concentrations after oral dosing.
Rochat B., Pascual A., Pesse B., Lamoth F., Sanglard D., Decosterd L.A., Bille J., Marchetti O., 2010. Antimicrobial Agents and Chemotherapy, 54 (12) pp. 5074-5081.
[DOI][WoS][Pmid][serval:BIB_F9010791A938]
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.
[URN][DOI][WoS][Pmid][serval:BIB_1123642915A2]
2009
 
Aspergillose invasive : perspectives en infectiologie préventive [Preventing invasive aspergillosis in hematopoietic stem cells transplant recipients]
Lamoth F., Bochud P.Y., 2009. Medecine sciences, 25 (8-9) pp. 669-672. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ACE6D7705813]
 
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Lamoth F., Erard V., Asner S., Buclin T., Calandra T., Marchetti O., 2009. International Journal of Antimicrobial Agents, 34 (4) pp. 386-388.
[DOI][WoS][Pmid][serval:BIB_E23443E778F9]
Imipenem underdosing as a cause of persistent neutropenic fever?
Lamoth F., Buclin T., Pascual A., Calandra T., Marchetti O., 2009. Journal of Antimicrobial Chemotherapy, 64 (3) pp. 665-667.
[URN][DOI][WoS][Pmid][serval:BIB_8C7E736FBB7C]
On track to limit antifungal overuse!
Eggimann P., Lamoth F., Marchetti O., 2009. Intensive Care Medicine, 35 (4) pp. 582-584. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0D6C7E366DF5]
Parachlamydia and rhabdochlamydia in premature neonates.
Lamoth Frederic, Aeby Sebastian, Schneider Antoine, Jaton-Ogay Katia, Vaudaux Bernard, Greub Gilbert, 2009. Emerging Infectious Diseases, 15 (12) pp. 2072-2075.
[URN][DOI][WoS][Pmid][serval:BIB_E9D34B54720E]
 
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.
[DOI][WoS][Pmid][serval:BIB_6BCA0E0A0A40]
 
Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.
Lamoth F., Buclin T., Csajka C., Pascual A., Calandra T., Marchetti O., 2009. Antimicrobial Agents and Chemotherapy, 53 (2) pp. 785-787. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3C81678B0325]
2008
 
Case Report: Human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008/10. Journal of Medical Virology, 80 (10) pp. 1804-1807.
[DOI][WoS][Pmid][serval:BIB_437055D50075]
 
Case report: human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient.
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008/10. Journal of medical virology, 80 (10) pp. 1804-1807. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9F51C3BA658B]
 
Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.
Leung Ki E.L., Venetz J.P., Meylan P., Lamoth F., Ruiz J., Pascual M., 2008. Clinical Transplantation, 22 (2) pp. 245-249.
[DOI][WoS][Pmid][serval:BIB_11733DE83D93]
 
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth Frederic, Pascual Manuel, Erard Veronique, Venetz Jean-Pierre, Nseir Ghaleb, Meylan Pascal, 2008. Antiviral Therapy, 13 (8) pp. 1001-1009. Peer-reviewed.
[WoS][Pmid][serval:BIB_9B931842FA7E]
 
What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?
Lamoth F., Manuel O., Venetz J.P., Faouzi M., Meylan P., Pascual M., 2008. Transplantation, 86 (9) pp. 1323-1324.
[DOI][WoS][Pmid][serval:BIB_82029D955FF2]
2007
Blood samples drawn for culture as a surrogate marker for case-mix adjustment of hospital antibiotic use.
Lamoth F., Francioli P., Zanetti G., 2007/04. Clinical Microbiology and Infection, 13 (4) pp. 454-456. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A84CCEE4B98A]
2006
 
Etat fébrile et Hépatosplénomégalie chez une femme de 25 ans: approche diagnostique [A 25-year-old woman with fever and hepatosplenomegaly: diagnostic approach]
Lamoth F., Chabanel D., Waeber G., 2006/07/05. Praxis, 95 (27-28) pp. 1081-1084. Peer-reviewed.
[Pmid][serval:BIB_099EF59845E1]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University